Jasper Therapeutics, Inc., 2026-08-05
An SEC Form D private-offering notice from Redwood City, CA, a $131,999,611 filer-stated offering target in Biotech. Filed 2026-08-05. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing briquilimab, an anti-KIT antibody depleting mast cells to treat chronic urticaria and allergic asthma
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Propy, Inc., 2026-08-05, $10M, San Francisco, CA
- Integrated Biosciences, Inc., 2026-08-05, $100M, Redwood City, CA
- OPEN DOORS PARTNERS, LLC, 2026-08-05, $7.9M, Woodside, CA
- Oncologic, Inc. / DE, 2026-08-05, $26.7M, Orlando, FL
- Potluck Media, Inc., 2026-08-05, $4M, Los Angeles, CA
- Insignis Therapeutics Inc., 2026-08-05, $8.5M, North Haven, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.